a) providing a urine samples from a patient suspected of containing cell-free, transrenal nucleic acids of the transplanted material, which transplanted material is located outside of the urinary tract from the cells, tissue or organs that are transplanted in areas other than the urinary tract in the patient; and b) quantitatively analyzing said urine sample for nucleic acids from the cell genome